Of note, a recent study indicated that simultaneous inhibition of glycolysis and abrogation of c-myc expression by 3-BrPA and bromodomain-containing protein 4 (BRD4) inhibitor ITH-47 that prevents the transcription of c-myc gene, a synergistic cell killing effect was obtained on U937 myeloid leukemia cells [101]. Here, BRD4 is linked to myeloid leukemia.